Development of Visual Function Evaluation Method (2)

Astellas logo

Astellas

Status

Completed

Conditions

Retinitis Pigmentosa

Study type

Observational

Funder types

Industry

Identifiers

NCT03626207
CLR180001

Details and patient eligibility

About

The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient.

Enrollment

8 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects with severe visual disturbance (count-fingers or worse vision for severe eyes) at the time of obtaining the consent and at screening

Exclusion criteria

  • Subjects should not have participated in any other clinical trial or clinical study involving visual function evaluation within 6 months
  • History of surgery, past history, and complications (cardiac/ hepatic/ renal/ respiratory/ hematological diseases, optic nerve diseases causing marked loss of visual field, and uveitis etc.) that potentially affect evaluation and safety of the study
  • Pregnant women
  • Subjects who are judged that continuation of the study is difficult during the study period
  • Subjects who are employed by the company sponsoring this study, an organization or institution related to this study

Trial design

8 participants in 1 patient group

Retinitis pigmentosa
Description:
Retinitis pigmentosa patients with severe visual impairment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems